Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of two homeopathic remedies—Rhus toxicodendron (commonly known as poison ivy) and Ruta graveolens (commonly known as rue)—used primarily in homeopathy for the symptomatic treatment of musculoskeletal pain, joint stiffness, inflammation, and rheumatic or arthritic conditions. This combination has been studied in the context of reducing joint pain and stiffness associated with aromatase inhibitor therapy in women with early breast cancer. Both remedies are believed to act by modulating symptoms related to connective tissue injury or inflammation; however, their mechanism is based on homeopathic principles rather than established pharmacological action. The combination is available in various potencies (e.g., 5CH/9CH) and forms including oral granules and topical creams[1][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rhus toxicodendron + ruta graveolens.